SCHEMBL12867149

SCHEMBL12867149

Cc1ccc(O)c(N)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
CASP1 P29466 1/20 0.46
PDE10A Q9Y233 1/20 0.46
TRPA1 O75762 2/20 0.44
ALDH1A1 P00352 6/20 0.43
HSD17B10 Q99714 3/20 0.41
ALOX15 P16050 2/20 0.41
GAA P10253 4/20 0.40
GFER P55789 1/20 0.40
TP53 P04637 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 3/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 2/20 0.36
PKM P14618 2/20 0.35
NPC1 O15118 1/20 0.35
MITF O75030 1/20 0.35
AGTR1 P30556 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3359993 0.83 POLB (0.48) TSHRCASP1PDE10ATRPA1ALDH1A1
SCHEMBL4968725 0.81 PDE10A (0.54) TSHRCASP1PDE10AALDH1A1HSD17B10
SCHEMBL31634585 0.81 PDE10A (0.54) TSHRCASP1PDE10AALDH1A1HSD17B10
SCHEMBL3371394 0.79 CD44 (0.44) TSHRCASP1PDE10ATRPA1ALDH1A1
SCHEMBL31495833 0.79 PDE10A (0.52) TSHRCASP1PDE10ATRPA1ALDH1A1
SCHEMBL118836 0.79 TSHR (0.46) TSHRCASP1PDE10ATRPA1ALDH1A1
SCHEMBL632398 0.77 ALDH1A1 (0.42) TSHRPDE10AALDH1A1HSD17B10ALOX15
SCHEMBL25370491 0.75 ALDH1A1 (0.40) TSHRCASP1PDE10ATRPA1ALDH1A1
SCHEMBL3790991 0.75 ALDH1A1 (0.47) TSHRCASP1PDE10AALDH1A1HSD17B10
SCHEMBL22363080 0.75 TSHR (0.43) TSHRCASP1PDE10ATRPA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8471043-B2 Platensimycin derivatives, their intermediates, and process for preparing the same, and new process for preparing platensimycin SNU R&DB FOUNDATION (KR) 2013-06-25 US disclosed
US-20110028741-A1 Novel Platensimycin Derivatives, Their Intermediates, and Process for Preparing the Same, and New Process for Preparing Platensimycin SNU R&DB FOUNDATION (KR) 2011-02-03 US disclosed
US-20110028741-A1 Novel Platensimycin Derivatives, Their Intermediates, and Process for Preparing the Same, and New Process for Preparing Platensimycin SNU R&DB FOUNDATION (KR) 2011-02-03 US disclosed
CN-1517794-A Resist composition 三菱瓦斯化学株式会社 2004-08-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028741-A1 Novel Platensimycin Derivatives, Their Intermediates, and Process for Preparing the Same, and New Process for Preparing Platensimycin RPN2, RPN1, DHPS TSHR 3867/4885CASP1 1636/4885PDE10A 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.